Standard BioTools Inc (LAB) Stock Analysis
Verdict: AVOID
Chronic revenue contraction and severe operational losses outweigh deep value metrics, suggesting a 'value trap' until growth stabilizes.
Investment score: 38/100
Analysis as of
Is Standard BioTools Inc stock worth reviewing? AI model thesis
Standard BioTools is in a state of fundamental decline, evidenced by shrinking revenues and massive operating losses. While the balance sheet is currently liquid, the pace of cash burn and technical breakdown suggest further downside before a sustainable floor is found.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 15/100 (weight 15%)
- Technical Momentum: 20/100 (weight 15%)
- Earnings Quality: 40/100 (weight 15%)
- Insider Sentiment: 55/100 (weight 10%)
- Analyst Consensus: 50/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
Standard BioTools Inc opportunities and risks
What speaks for LAB
- Liquidation Value Play
What speaks against LAB
- Continued Negative Free Cash Flow Burn
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| LAB | n/a | 3.1x | n/a | 49.1% | -103.3% | -31.4% |
| CTKB | n/a | 2.9x | n/a | 53.2% | -39.0% | -2.0% |
| OABI | n/a | 15.8x | n/a | 50.5% | -115.2% | -3.0% |
| DNA | n/a | 4.5x | n/a | 80.1% | -260.0% | -37.7% |
| PACB | n/a | 2.5x | n/a | 36.0% | -82.5% | -43.4% |
| TKNO | n/a | 8.8x | n/a | 33.9% | -38.4% | -1.9% |
| Peer median | n/a | 4.5x | n/a | 50.5% | -82.5% | -3.0% |
Frequently asked questions about Standard BioTools Inc (LAB)
Is LAB stock a good investment?
The cached TradeMates AI model rates Standard BioTools Inc as AVOID with an investment score of 38/100. Standard BioTools is in a state of fundamental decline, evidenced by shrinking revenues and massive operating losses. While the balance sheet is currently liquid, the pace of cash burn and technical breakdown suggest further downside before a sustainable floor is found. This is algorithmic model output, not personal investment advice.
Is LAB stock a buy?
The TradeMates model verdict for LAB is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.